GATT Versus Canaloplasty (GVC)
- Conditions
- Glaucoma, Open-Angle
- Interventions
- Procedure: canaloplastyProcedure: Gonioscopy-assisted Transluminal Trabeculotomy
- Registration Number
- NCT05366647
- Lead Sponsor
- Medical University of Bialystok
- Brief Summary
Study aims to compare the effectiveness and safety profile of Gonioscopy-assisted Transluminal Trabeculotomy and canaloplasty, in order to find out if one operation is superior to the other. Both procedures are performed in patients with medically uncontrolled open-angle glaucoma. Canaloplasty is a recently newly introduced procedure, which showed encouraging results without antimetabolite usage intra- and postoperatively. Gonioscopy-assisted Transluminal Trabeculotomy is the procedure that aims the same mechanism of aqueous outflow, however is perform with ab interno approach, which comprise it to the minimally invasive glaucoma surgery techniques. Purpose of the study is to compare both surgeries concerning success rate, intraocular pressure, medication burden and complications rate. So far there is no comparison of the Gonioscopy-assisted Transluminal Trabeculotomy and canaloplasty available.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
- 18 Years and older (Adult, Older Adult)
- patients with confirmed uncontrolled open angle glaucoma
- no prior glaucoma surgery (once laser trabeculoplasty or cyclophotocoagulation) allowed
- angle closure glaucoma
- congenital glaucoma
- inflammatory glaucoma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Gonioscopy-assisted Transluminal Trabeculotomy canaloplasty Gonioscopy-assisted Transluminal Trabeculotomy ab interno Canaloplasty Gonioscopy-assisted Transluminal Trabeculotomy Canaloplasty ab externo
- Primary Outcome Measures
Name Time Method success rate (complete and qualified success) 24 months Success is defined: 1. IOP \< 21 mmHg and at least 20% IOP change from baseline 2. IOP \< 18 mmHg
- Secondary Outcome Measures
Name Time Method IOP, medication, complications 24 months intraocular pressure change, medication postoperatively, complications intra- and postoperatively
Trial Locations
- Locations (1)
Ophthalmology Clinic Medical University of Bialystok
🇵🇱Białystok, Poland